LifeStance Health Group, Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($215.6m) ($186.3m) ($57.4m) $9.7m
Net Income (Loss) Attributable to Parent $5.7m ($307.2m) ($215.6m) ($186.3m) ($57.4m) $9.7m
Net Income (Loss) Available to Common Stockholders, Basic $5.7m ($343.9m) ($215.6m) ($186.3m) ($57.4m) $9.7m
Adjustments to reconcile profit (loss) $48.4m $16.9m $3.0m $26.6m $25.9m $38.2m $36.8m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($307.2m) ($215.6m) ($186.3m) ($57.4m) $9.7m
Depreciation, Depletion and Amortization $6.1m $14.6m $15.1m $28.9m $37.4m $40.7m $41.6m $22.1m
Amortization of Debt Issuance Costs $1.8m $1.9m $2.1m $1.7m $1.0m
Amortization of Intangible Assets $39.0m $40.3m $43.1m $30.3m $13.1m
Amortization of discount and debt issue costs $707k $1.8m $1.9m $2.1m $1.7m $1.0m
Amortization Cash Flow $40.3m $43.1m $30.3m $13.1m
Amortization Of Intangibles $40.3m $43.1m $30.3m $13.1m
Depreciation Amortization Depletion $69.2m $80.4m $71.0m $54.8m
Deferred Income Tax Expense (Benefit) ($26.9m) ($16.7m) ($21.9m) ($958k) $2.0m
Deferred income taxes $1.8m ($26.9m) ($16.7m) ($21.9m) ($958k) $2.4m
Deferred taxes ($3.2m) ($3.8m) ($3.0m) ($6.8m) ($256k) $1.5m ($1.5m)
Deferred Income Tax ($16.7m) ($21.9m) ($958k) $2.4m
Deferred Tax ($16.7m) ($21.9m) ($958k) $2.4m
Share-based Payment Arrangement, Noncash Expense $259.4m $187.4m $99.4m $76.2m $74.7m
Payment, Tax Withholding, Share-based Payment Arrangement $441k $904k $0 $0 $8.7m
Goodwill, Impairment Loss $0 $0 $0 $0
Restructuring Costs and Asset Impairment Charges $4.7m
Share-based compensation $2.9m $5.6m $3.3m $6.7m $4.9m $4.0m $5.5m
Impairment of goodwill and intangibles $0 $5.1m $41.1m
Share-based compensation granted on business acquisition $0 ($1.3m) $0
Gain (Loss) on Disposition of Assets ($218k)
Gain (Loss) on Extinguishment of Debt ($14.4m) ($3.4m) $0 ($5.0m) $0
Income Tax Expense (Benefit) ($25.9m) ($17.2m) ($20.3m) ($170k) $2.7m
Interest Expense Nonoperating $26.5m $11.7m
Loss on debt extinguishment $0 $14.4m $3.4m $0 $5.0m $0
Operating lease liabilities $0 ($13.2m) ($37.6m) ($46.7m) ($48.1m)
Changes in operating assets and liabilities:
Changes in non-cash working capital items $5.7m ($86k) ($1.1m) $2.3m ($10.2m) $10.2m ($11.0m)
Additional Financial Items
Increase (Decrease) in Accounts Receivable $24.2m $21.7m $24.2m $6.4m ($36.1m)
Increase (Decrease) in Accounts Payable $623k $7.7m ($5.6m) $501k ($1.6m)
Accretion Expense, Including Asset Retirement Obligations $11.4m $15.7m
Goodwill $1.2b $1.3b $1.3b $1.3b $1.3b
Nonoperating Income (Expense) ($46.8m) ($22.6m) ($17.4m) ($26.0m) ($11.8m)
Operating Expenses $953.9m $1.1b $1.2b $1.3b $1.4b
Proceeds from Contributions from Affiliates $1.0m $0 $0
Revenue from Contract with Customer, Including Assessed Tax $667.5m $859.5m $1.1b $1.3b $1.4b
Stock-based compensation $54k $259.4m $187.4m $99.4m $76.2m $74.7m
Gain on remeasurement of contingent consideration ($229k) $2.6m $1.7m ($4.0m) ($1.7m) $0
Other, net $0 $218k $7.1m $1.4m $2.0m
Patient accounts receivable, net ($5.8m) ($24.2m) ($21.7m) ($24.2m) ($6.4m) $36.1m
Prepaid expenses and other current assets ($2.2m) ($29.1m) ($3.4m) ($3.1m) ($3.3m) ($46.7m)
Accounts payable $2.5m $623k $7.7m ($5.6m) $501k ($1.6m)
Accrued payroll expenses $5.2m $15.3m $12.1m $26.5m $15.0m $25.9m
Other accrued expenses $3.2m $39.6m $1.6m $10.2m $13.6m ($5.9m)
Payments of contingent consideration ($5.0m) ($12.3m) ($12.5m) ($7.7m) ($6.4m) $0
Taxes related to net share settlement of equity awards $0 $441k ($904k) $0 $0 ($8.7m)
Equipment financed through finance leases $1.4m $363k $0 $0
Contingent consideration incurred in acquisitions of businesses $22.9m $10.7m $11.2m $2.0m $0 $0
Acquisition of property and equipment included in liabilities $1.2m $0 $15.8m $7.9m $3.8m $1.5m $2.9m $515k
Surrender of common stock $0 $982k $0 $0
Net (loss) earnings ($39.7m) ($17.3m) ($15.5m) ($30.1m) ($16.7m) $1.3m ($38.8m)
Change in fair value of contingent consideration $0 $9.2m ($3.8m) ($5.6m) ($2.1m)
Net financial expenses $231k $242k $4.6m $9.3m $11.9m $8.9m $9.5m
Unrealized foreign exchange loss (gain) $273k $1.3m $299k ($318k) $153k ($966k) $1.0m
Cash settlement of RSUs, DSUs and PSUs ($371k) ($264k) $0
Additions to intangibles ($49k) ($166k) ($1.4m) ($849k) ($41k) ($239k) ($316k)
Advances on the Credit Facility, net of related transaction costs $64.1m $53.5m $156.8m $98.7m $148.3m $102.7m $61.4m
Repayment of the Credit Facility ($54.4m) ($49.9m) ($146.5m) ($97.5m) ($159.1m) ($110.3m) ($50.8m)
Repayment of secured loans ($8.5m) $0
Repayment of balances of purchase price payable ($4.3m) ($7.7m)
Repayment of lease liabilities, including lease termination costs ($1.8m) ($1.4m) ($2.7m) ($3.7m) ($5.8m) ($4.6m) ($3.8m)
Exercise of stock options $165k $300k $299k $346k $6k $0 $100k
Shares purchased for settlement of RSUs $0 $0 ($29k) $0 ($148k) ($205k)
Shares purchased for cancellation $0 ($1.2m) ($1.0m) ($953k) ($402k) ($5.2m)
Financial expenses paid $3.5m $8.1m ($11.0m) ($8.0m) ($8.1m)
Cash, beginning of year ($4.0m) ($1.9m) $10.8m $4.9m ($13.7m) $7.1m ($3.1m)
Cash, end of year $12.8m $8.8m $17.7m $17.7m $8.9m $16.0m $12.8m
Other $0 ($138k) ($533k) $0 ($290k) $0
Settlement of RSUs $0 ($371k)
Forgiveness of PPP loans $0 ($1.9m) ($5.9m) $0
Loss on disposal of intangibles $28.0m $0 $262k $0
Right-of-use assets $222k $0 ($132k) $0
Proceeds from issuing shares $24.7m $0
Lease incentives $0 $917k $0
Interest accretion on balances of purchase payable $318k $835k $823k
Gain on sale of subsidiary ($681k) $0
Short-term deposits $1.3m $0
Line of credit and demand loan drawn (repaid) ($3.2m) $0
Beginning Cash Position $148.0m $108.6m $78.8m $154.6m
Cash Flow From Continuing Financing Activities $47.3m $47.4m ($9.9m) ($16.0m)
Cash Flow From Continuing Investing Activities ($139.5m) ($60.3m) ($21.6m) ($36.1m)
Change In Account Payable $7.7m ($5.6m) $501k ($1.6m)
Change In Accrued Expense $13.7m $36.7m $28.6m $19.9m
Change In Other Current Liabilities ($13.2m) ($37.6m) ($46.7m) ($48.1m)
Change In Payable $7.7m ($5.6m) $501k ($1.6m)
Change In Payables And Accrued Expense $21.3m $31.1m $29.1m $18.4m
Change In Prepaid Assets ($3.4m) ($3.1m) ($3.3m) ($46.7m)
Change In Receivables ($21.7m) ($24.2m) ($6.4m) $36.1m
Change In Working Capital ($16.9m) ($33.7m) ($27.4m) ($40.3m)
Changes In Account Receivables ($21.7m) ($24.2m) ($6.4m) $36.1m
Changes In Cash ($39.4m) ($29.8m) $75.7m $94.1m
End Cash Position $108.6m $78.8m $154.6m $248.6m
Financing Cash Flow $47.3m $47.4m ($9.9m) ($16.0m)
Free Cash Flow ($26.5m) ($57.4m) $85.7m $110.0m
Investing Cash Flow ($139.5m) ($60.3m) ($21.6m) ($36.1m)
Issuance Of Capital Stock $549.9m $0 $0
Net Business Purchase And Sale ($60.2m) ($19.8m) $0 $0
Net PPE Purchase And Sale ($79.3m) ($40.5m) ($21.6m) ($36.1m)
Net Preferred Stock Issuance $0 $0
Operating Gains Losses $14.4m $3.4m $5.0m
Other Non Cash Items $42.0m $45.2m $40.9m $45.0m
Preferred Stock Payments $0 $0
Purchase Of Business ($60.2m) ($19.8m) $0 $0
Purchase Of PPE ($79.3m) ($40.5m) ($21.6m) ($36.1m)
Repurchase Of Capital Stock $0 $0
Net Cash Provided by (Used in) Operating Activities $17.0m $8.7m $9.4m $52.8m ($16.9m) $107.3m $146.2m $25.8m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment ($14.3m) ($4.5m) $94.5m $79.3m $40.5m $21.6m $36.1m ($1.4m)
Payments to Acquire Businesses, Net of Cash Acquired $99.6m $60.2m $19.8m $0 $0
Acquisitions of businesses, net of cash acquired ($59.1m) ($99.6m) ($60.2m) ($19.8m) $0 $0
Business acquisitions, net of cash acquired ($15.2m) $0 ($15.7m) ($14.4m) $0 ($6.4m) ($10.9m)
Business divestiture, cash disposed $0 ($951k)
Net Cash Provided by (Used in) Investing Activities ($73.4m) ($18.2m) ($194.1m) ($139.5m) ($60.3m) ($21.6m) ($36.1m) ($13.6m)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $98.8m $257.3m $57.8m $287.8m $0
Proceeds from long-term debt, net of discount $55.9m $98.8m $257.3m $57.8m $287.8m $0
Payments of debt issue costs ($2.0m) ($2.4m) ($7.3m) ($188k) ($1.8m) $0
Issuance Of Debt $257.3m $57.8m $287.8m $0
Long Term Debt Issuance $257.3m $57.8m $287.8m $0
Net Issuance Payments Of Debt $69.6m $55.3m ($1.7m) ($7.2m)
Net Long Term Debt Issuance $69.6m $55.3m ($1.7m) ($7.2m)
Repayments of Long-term Debt $311.4m $187.8m $2.5m $289.5m $7.2m
Payments of long-term debt ($488k) ($311.4m) ($187.8m) ($2.5m) ($289.5m) ($7.2m)
Prepayment for debt paydown $0 ($8.8m) ($1.6m) $0 $0
Realized foreign exchange (gain) loss on repayment of long-term debt $81k ($879k) ($250k) $861k ($26k) $580k ($604k)
Repayment of other long-term debt ($450k) ($350k)
Long Term Debt Payments ($187.8m) ($2.5m) ($289.5m) ($7.2m)
Repayment Of Debt ($187.8m) ($2.5m) ($289.5m) ($7.2m)
Common Stock Issuance $549.9m $0 $0
Net Common Stock Issuance $549.9m $0 $0
Net Other Financing Charges ($22.3m) ($7.9m) ($8.3m) ($8.7m)
Net cash (used in) provided by financing activities $48.5m $313.9m $47.3m $47.4m ($9.9m) ($16.0m)
Net cash (used in) from financing activities $4.9m $3.4m $27.9m ($11.3m)
Net Cash Provided by (Used in) Financing Activities $313.9m $47.3m $47.4m ($9.9m) ($16.0m) ($14.7m)
Effect of exchange rate changes on cash $579k ($308k) ($77k) $1.1m ($29k) $636k ($596k)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $129.2m ($39.4m) ($29.8m) $75.7m $94.1m
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS ($7.9m) $129.2m ($39.4m) ($29.8m) $75.7m $94.1m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $148.0m $108.6m $78.8m $154.6m $248.6m
Cash and cash equivalents - beginning of period $3.5m $148.0m $108.6m $78.8m $154.6m $248.6m
Restricted cash $47k ($1.0m) ($21k) $3.3m $0
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported ($39.4m) ($29.8m) $75.7m $94.1m
Interest Paid, Excluding Capitalized Interest, Operating Activities $4.6m $1.6m $22.4m $14.4m $21.0m $25.0m $17.8m
Income Taxes Paid, Net $254k $420k $1.1m $2.2m $80k $57k $1.6m ($72k)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.